Kyntra BioKYNB
13F holders, Q1 2026 (March 31)32holders −2
4new positions
7sold out
1famous investor
$6.78avg. 13F price*
At the end of Q1 2026, 32 institutions reported holding Kyntra Bio Inc. (KYNB) in their 13F filings, down 2 from Q4 2025. 4 opened new positions and 7 sold out. The largest holders were Armistice Capital, LLC ($2.7M), Vanguard Capital Management LLC ($1.1M) and Acadian Asset Management LLC ($714K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Kyntra Bio Inc.
- CUSIP
- 31572Q881
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $156K |
| Exits | 7 | $1.0M |
All 13F filers, Q4 2025 → Q1 2026: 43,608 shares bought and 137,387 shares sold, net −93,779 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 32 holders
| Armistice Capital, LLC | 0.09% | No change | 400,000 | $2.7M |
| Vanguard Capital Management LLC | 0.00% | — | 156,607 | $1.1M |
| Acadian Asset Management LLC | 0.00% | No change | 105,585 | $714K |
| BlackRock, Inc. | 0.00% | Reduce -0.4% | 84,331 | $572K |
| Two Sigma Investments, LP | 0.00% | Reduce -19.1% | 49,511 | $336K |
| Geode Capital Management, LLC | 0.00% | Add +5.3% | 45,998 | $312K |
| HighTower Advisors, LLC | 0.00% | Reduce -0.0% | 39,744 | $269K |
| UBS Group AG | 0.00% | Add +192.5% | 27,591 | $187K |
| Renaissance Technologies | 0.00% | Reduce -13.3% | 27,481 | $186K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 23,942 | $162K |
| Birchview Capital, LP | 0.09% | New | 22,566 | $153K |
| State Street Corp. | 0.00% | No change | 20,284 | $138K |
| Jane Street Group, LLC | 0.00% | Reduce -2.1% | 12,228 | $83K |
| ADAR1 Capital Management, LLC | 0.00% | No change | 10,469 | $71K |
| Group One Trading LLC | 0.00% | Reduce -2.1% | 4,492 | $30K |
| Vanguard Global Advisers, LLC | 0.00% | — | 1,424 | $10K |
| Axiom Investment Management LLC | 0.00% | — | 704 | $5K |
| Morgan Stanley | 0.00% | Reduce -91.8% | 488 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +53.7% | 332 | $2K |
| Harbour Investments, Inc. | 0.00% | New | 200 | $1K |
| National Bank of Canada | 0.00% | New | 193 | $1K |
| Osaic Holdings, Inc. | 0.00% | Add +76.5% | 180 | $1K |
| SBI Securities Co., Ltd. | 0.00% | No change | 152 | $1K |
| Royal Bank of Canada | 0.00% | Reduce -0.7% | 137 | $1K |
| BNP Paribas Financial Markets | 0.00% | Add +2.0% | 50 | $339 |
| Cwm, LLC | 0.00% | No change | 26 | $176 |
| JPMorgan Chase & Co. | 0.00% | No change | 12 | $78 |
| CFG Wealth Management Services, Inc. | 0.00% | No change | 3 | $20 |
| US Bancorp \de | 0.00% | No change | 1 | $7 |
| Danske Bank A/S | 0.00% | No change | 1 | $7 |
| Citigroup Inc. | 0.00% | New | 1 | $7 |
| Smithfield Trust Co | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is KYNB's weight in each manager's 13F, not the share of Kyntra Bio Inc. the manager owns.